Niall J O'Sullivan, Hugo C Temperley, Eimear T Kyle, Kevin J Sweeney, Maeve O'Neill, Charles Gilham, Jacintha O'Sullivan, Grainne O'Kane, Brian Mehigan, Sharon O'Toole, John Larkin, David Gallagher, Paul McCormick, Michael E Kelly
INTRODUCTION: Circulating tumour DNA (ctDNA) has emerged as a promising biomarker in various cancer types, including locally advanced rectal cancer (LARC), offering potential insights into disease progression, treatment response and recurrence. This review aims to comprehensively evaluate the utility of ctDNA as a prognostic biomarker in LARC. METHODS: PubMed, EMBASE and Web of Science were searched as part of our review. Studies investigating the utility of ctDNA in locally advanced rectal cancer (LARC) were assessed for eligibility...
May 29, 2024: International Journal of Colorectal Disease